County-Level Socioeconomic Status and Survival After HIV Diagnosis, United States

被引:47
作者
Harrison, Kathleen McDavid [1 ]
Ling, Qiang [1 ]
Song, Ruiguang [1 ]
Hall, H. Irene [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA
关键词
HIV surveillance; Race/ethnicity; Relative survival; Socioeconomic status; United States;
D O I
10.1016/j.annepidem.2008.09.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: To estimate relative survival (RS) after human immunodeficiency virus (HIV) diagnosis, by race/ethnicity and county-level socioeconomic status (SES). METHODS: We estimated 5-year RS by age, race/ethnicity, transmission category, sex, diagnosis year, CD4 count, and by county-level SES variables from the U.S. Census. Data, from the national HIV/AIDS Reporting System, were for HIV-infected persons ages >= 13 years (diagnosis during 1996-2003 and follow-up through 2005). We calculated RS proportions by using a maximum likelihood algorithm and modeled the relative risk of excess death (RR) using generalized linear models, with poverty as a random effect. RESULTS: For men, RS was worse in Counties with larger proportions of people living below the 2000 U.S. poverty level (87.7% for poverty of >= 20% vs. 90.1% for poverty of < 5.0%) and where unemployment was greater (87.8% where unemployment > 7.1% vs. 90.5% where unemployment < 4.0%). The effects of county-level SES on RS of women were similar. In multilevel multivariate models, RR for men and women within 5 years after an HIV diagnosis was significantly worse in counties where 10.0-19.9% (compared with < 5.0%) lived below the poverty level (RR = 1.3 [95% CI 1.2-1.5] and RR = 1.8 [95% CI 1.4-2.2], respectively). CONCLUSIONS: RS was worse in lower SES areas. To help address the impact of county-level SES, resources for HIV testing, care, and proven economic interventions should be directed to areas with concentrations of economically disadvantaged people.
引用
收藏
页码:919 / 927
页数:9
相关论文
共 74 条
[11]  
Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P89
[12]   RACE, SEX, DRUG-USE, AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
CHAISSON, RE ;
KERULY, JC ;
MOORE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :751-756
[13]   Recipients in need of ancillary services and their receipt of HIV medical care in California [J].
Chan, D ;
Absher, D ;
Sabatier, S .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2002, 14 :S73-S83
[14]   Medically eligible women who do not use HAART: The importance of abuse, drug use, and race [J].
Cohen, MH ;
Cook, JA ;
Grey, D ;
Young, M ;
Hanau, LH ;
Tien, P ;
Levine, AM ;
Wilson, TE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (07) :1147-1151
[15]   The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States [J].
Cunningham, WE ;
Andersen, RM ;
Katz, MH ;
Stein, MD ;
Turner, BJ ;
Crystal, S ;
Zierler, S ;
Kuromiya, K ;
Morton, SC ;
St Clair, P ;
Bozzette, SA ;
Shapiro, MF .
MEDICAL CARE, 1999, 37 (12) :1270-1281
[16]   Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men [J].
Davidson, AJ ;
Bertram, SL ;
Lezotte, DC ;
Marine, WM ;
Rietmeijer, CA ;
Hagglund, BB ;
Cohn, DL .
MEDICAL CARE, 1998, 36 (12) :1676-1684
[17]   SOCIOECONOMIC DIFFERENCES AMONG PEOPLE WITH AIDS - RESULTS FROM A MULTISTATE SURVEILLANCE PROJECT [J].
DIAZ, T ;
CHU, SY ;
BUEHLER, JW ;
BOYD, D ;
CHECKO, PJ ;
CONTI, L ;
DAVIDSON, AJ ;
HERMANN, P ;
HERR, M ;
LEVY, A ;
SHIELDS, A ;
SORVILLO, F ;
MOKOTOFF, E ;
WHYTE, B ;
HERSH, BS .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1994, 10 (04) :217-222
[18]   Regression models for relative survival [J].
Dickman, PW ;
Sloggett, A ;
Hills, M ;
Hakulinen, T .
STATISTICS IN MEDICINE, 2004, 23 (01) :51-64
[19]  
EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101
[20]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129